US3256153A
(en)
|
1963-02-08 |
1966-06-14 |
Smith Kline French Lab |
Method of stabilizing wax-fat coating materials and product thereof
|
US4003792A
(en)
|
1967-07-01 |
1977-01-18 |
Miles Laboratories, Inc. |
Conjugates of acid polysaccharides and complex organic substances
|
US3950517A
(en)
|
1970-05-08 |
1976-04-13 |
National Research Development Corporation |
Insulin derivatives
|
GB1381274A
(en)
|
1971-01-28 |
1975-01-22 |
Nat Res Dev |
Insulin derivatives
|
US3919411A
(en)
|
1972-01-31 |
1975-11-11 |
Bayvet Corp |
Injectable adjuvant and compositions including such adjuvant
|
US4044196A
(en)
|
1972-03-30 |
1977-08-23 |
Bayer Aktiengesellschaft |
Crosslinked copolymers of α,β-olefinically unsaturated dicarboxylic anhydrides
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
FR2408387A2
(fr)
|
1975-06-30 |
1979-06-08 |
Oreal |
Compositions a base de dispersions aqueuses de spherules lipidiques
|
US4093574A
(en)
|
1977-02-02 |
1978-06-06 |
Eli Lilly And Company |
Somatostatin analogs and intermediates thereto
|
US4087390A
(en)
|
1977-02-02 |
1978-05-02 |
Eli Lilly And Company |
Somatostatin analogs and intermediates thereto
|
JPS53116315A
(en)
|
1977-03-17 |
1978-10-11 |
Ueno Seiyaku Oyo Kenkyujo Kk |
Powder or granular containing improved sorbinic acid
|
US4100117A
(en)
|
1977-04-21 |
1978-07-11 |
Eli Lilly And Company |
Somatostatin analogs and intermediates thereto
|
US4253998A
(en)
|
1979-03-09 |
1981-03-03 |
American Home Products Corporation |
Peptides related to somatostatin
|
JPS54148722A
(en)
|
1978-05-12 |
1979-11-21 |
Takeda Chem Ind Ltd |
Nonapeptide and its preparation
|
US4277394A
(en)
|
1979-04-23 |
1981-07-07 |
Takeda Chemical Industries, Ltd |
Tetrapeptidehydrazide derivatives
|
GB2051574B
(en)
|
1979-05-10 |
1984-01-18 |
Kyoto Pharma Ind |
Adjuvant for promoting absorption of pharmacologically active substances through the rectum
|
US4348387A
(en)
|
1979-07-31 |
1982-09-07 |
The Rockefeller University |
Method and system for the controlled release of biologically active substances to a body fluid
|
US4469681A
(en)
|
1979-07-31 |
1984-09-04 |
The Rockefeller University |
Method and system for the controlled release of biologically active substances to a body fluid
|
FR2465486A1
(fr)
|
1979-09-21 |
1981-03-27 |
Roussel Uclaf |
Nouvelle application utilisant la lh-rh ou des agonistes
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
US4698264A
(en)
|
1982-08-02 |
1987-10-06 |
Durkee Industrial Foods, Corp. |
Particulate composition and process for making same
|
IL68769A
(en)
|
1983-05-23 |
1986-02-28 |
Hadassah Med Org |
Pharmaceutical compositions containing insulin for oral administration
|
US4585754A
(en)
|
1984-01-09 |
1986-04-29 |
Valcor Scientific, Ltd. |
Stabilization of proteins and peptides by chemical binding with chondroitin
|
US4684524A
(en)
|
1984-03-19 |
1987-08-04 |
Alza Corporation |
Rate controlled dispenser for administering beneficial agent
|
US4717566A
(en)
|
1984-03-19 |
1988-01-05 |
Alza Corporation |
Dosage system and method of using same
|
US4963367A
(en)
|
1984-04-27 |
1990-10-16 |
Medaphore, Inc. |
Drug delivery compositions and methods
|
US4849405A
(en)
|
1984-05-09 |
1989-07-18 |
Synthetic Blood Corporation |
Oral insulin and a method of making the same
|
US4839341A
(en)
|
1984-05-29 |
1989-06-13 |
Eli Lilly And Company |
Stabilized insulin formulations
|
US4622392A
(en)
|
1984-06-21 |
1986-11-11 |
Health Research Inc. (Roswell Park Division) |
Thiophospholipid conjugates of antitumor agents
|
US4629621A
(en)
|
1984-07-23 |
1986-12-16 |
Zetachron, Inc. |
Erodible matrix for sustained release bioactive composition
|
US4797288A
(en)
|
1984-10-05 |
1989-01-10 |
Warner-Lambert Company |
Novel drug delivery system
|
US4946828A
(en)
|
1985-03-12 |
1990-08-07 |
Novo Nordisk A/S |
Novel insulin peptides
|
US5157021A
(en)
|
1985-03-15 |
1992-10-20 |
Novo Nordisk A/S |
Insulin derivatives and pharmaceutical preparations containing these derivatives
|
DK129385A
(da)
*
|
1985-03-22 |
1986-09-23 |
Novo Industri As |
Peptider og fremstilling deraf
|
US4917888A
(en)
|
1985-06-26 |
1990-04-17 |
Cetus Corporation |
Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
|
SE457326B
(sv)
|
1986-02-14 |
1988-12-19 |
Lejus Medical Ab |
Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
|
ZA877505B
(en)
|
1986-10-14 |
1989-05-30 |
Lilly Co Eli |
Process for transforming a human insulin precursor to human insulin
|
GB8706313D0
(en)
|
1987-03-17 |
1987-04-23 |
Health Lab Service Board |
Treatment & prevention of viral infections
|
US5093198A
(en)
|
1987-06-19 |
1992-03-03 |
Temple University |
Adjuvant-enhanced sustained release composition and method for making
|
DE3721721C1
(de)
|
1987-07-01 |
1988-06-09 |
Hoechst Ag |
Verfahren zur Umhuellung von Granulaten
|
US5080891A
(en)
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
JPH01308231A
(ja)
|
1988-06-03 |
1989-12-12 |
Takeda Chem Ind Ltd |
安定化された医薬組成物および製造法
|
US5055300A
(en)
|
1988-06-17 |
1991-10-08 |
Basic Bio Systems, Inc. |
Time release protein
|
DK336188D0
(da)
|
1988-06-20 |
1988-06-20 |
Nordisk Gentofte |
Propeptider
|
ES2061797T3
(es)
*
|
1988-06-23 |
1994-12-16 |
Hoechst Ag |
Mini-proinsulina, su preparacion y empleo.
|
US5162430A
(en)
|
1988-11-21 |
1992-11-10 |
Collagen Corporation |
Collagen-polymer conjugates
|
US5306500A
(en)
|
1988-11-21 |
1994-04-26 |
Collagen Corporation |
Method of augmenting tissue with collagen-polymer conjugates
|
WO1990007522A1
(en)
|
1988-12-23 |
1990-07-12 |
Novo Nordisk A/S |
Human insulin analogues
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
US5089261A
(en)
|
1989-01-23 |
1992-02-18 |
Cetus Corporation |
Preparation of a polymer/interleukin-2 conjugate
|
US5182258A
(en)
|
1989-03-20 |
1993-01-26 |
Orbon Corporation |
Systemic delivery of polypeptides through the eye
|
US5324844A
(en)
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
US5286637A
(en)
|
1989-08-07 |
1994-02-15 |
Debiopharm, S.A. |
Biologically active drug polymer derivatives and method for preparing same
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5312808A
(en)
|
1989-11-22 |
1994-05-17 |
Enzon, Inc. |
Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
|
US5650388A
(en)
|
1989-11-22 |
1997-07-22 |
Enzon, Inc. |
Fractionated polyalkylene oxide-conjugated hemoglobin solutions
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
US5595732A
(en)
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
DK0580778T3
(da)
|
1991-04-19 |
2000-01-31 |
Lds Technologies Inc |
Konvertible mikroemulsionsformuleringer
|
US5304473A
(en)
|
1991-06-11 |
1994-04-19 |
Eli Lilly And Company |
A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
US5693769A
(en)
|
1991-12-13 |
1997-12-02 |
Transcell Technologies, Inc. |
Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
|
GB9212511D0
(en)
*
|
1992-06-12 |
1992-07-22 |
Cortecs Ltd |
Pharmaceutical compositions
|
US5262172A
(en)
|
1992-06-19 |
1993-11-16 |
Digestive Care Inc. |
Compositions of gastric acid-resistant microspheres containing buffered bile acids
|
US5415872A
(en)
|
1992-06-22 |
1995-05-16 |
Digestive Care Inc. |
Compositions of gastric acid-resistant microspheres containing salts of bile acids
|
JPH0635027A
(ja)
*
|
1992-07-22 |
1994-02-10 |
Nikon Corp |
カメラの自動露出装置及びカメラの測光装置
|
US6093391A
(en)
*
|
1992-10-08 |
2000-07-25 |
Supratek Pharma, Inc. |
Peptide copolymer compositions
|
GB9316895D0
(en)
|
1993-08-13 |
1993-09-29 |
Guy S And St Thomas Hospitals |
Hepatoselective insulin analogues
|
US5298643A
(en)
|
1992-12-22 |
1994-03-29 |
Enzon, Inc. |
Aryl imidate activated polyalkylene oxides
|
US5349001A
(en)
|
1993-01-19 |
1994-09-20 |
Enzon, Inc. |
Cyclic imide thione activated polyalkylene oxides
|
US5321095A
(en)
|
1993-02-02 |
1994-06-14 |
Enzon, Inc. |
Azlactone activated polyalkylene oxides
|
US5298410A
(en)
|
1993-02-25 |
1994-03-29 |
Sterling Winthrop Inc. |
Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
US5681811A
(en)
|
1993-05-10 |
1997-10-28 |
Protein Delivery, Inc. |
Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
|
US6191105B1
(en)
*
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US5747445A
(en)
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
CN1056618C
(zh)
|
1993-09-17 |
2000-09-20 |
诺沃挪第克公司 |
酰化的胰岛素和含有这种胰岛素的药物组合物
|
US5919455A
(en)
*
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5605976A
(en)
|
1995-05-15 |
1997-02-25 |
Enzon, Inc. |
Method of preparing polyalkylene oxide carboxylic acids
|
DE69434626D1
(de)
|
1993-11-17 |
2006-04-20 |
Athena Neurosciences Inc |
Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
|
US5504188A
(en)
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5730990A
(en)
*
|
1994-06-24 |
1998-03-24 |
Enzon, Inc. |
Non-antigenic amine derived polymers and polymer conjugates
|
GB9417524D0
(en)
|
1994-08-31 |
1994-10-19 |
Cortecs Ltd |
Pharmaceutical compositions
|
US5738846A
(en)
|
1994-11-10 |
1998-04-14 |
Enzon, Inc. |
Interferon polymer conjugates and process for preparing the same
|
US5646242A
(en)
*
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
CA2206852A1
(en)
|
1994-12-07 |
1996-06-13 |
Novo Nordisk A/S |
Polypeptide with reduced allergenicity
|
BR9408638A
(pt)
*
|
1994-12-29 |
2004-09-21 |
Bio Technology General Corp |
Geração de insulina humana
|
US5932462A
(en)
*
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
US5907030A
(en)
*
|
1995-01-25 |
1999-05-25 |
University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
US6251856B1
(en)
*
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
AR002976A1
(es)
*
|
1995-03-31 |
1998-05-27 |
Lilly Co Eli |
Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
|
US5606038A
(en)
|
1995-04-10 |
1997-02-25 |
Competitive Technologies, Inc. |
Amphiphilic polyene macrolide antibiotic compounds
|
DE741187T1
(de)
*
|
1995-05-05 |
1997-04-30 |
Hoffmann La Roche |
Rekombinante Obesitäts-(OB)-Proteine
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
US5700904A
(en)
|
1995-06-07 |
1997-12-23 |
Eli Lilly And Company |
Preparation of an acylated protein powder
|
US5631347A
(en)
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
GB9516268D0
(en)
*
|
1995-08-08 |
1995-10-11 |
Danbiosyst Uk |
Compositiion for enhanced uptake of polar drugs from the colon
|
US5766620A
(en)
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
US5948751A
(en)
*
|
1996-06-20 |
1999-09-07 |
Novo Nordisk A/S |
X14-mannitol
|
US5866538A
(en)
*
|
1996-06-20 |
1999-02-02 |
Novo Nordisk A/S |
Insulin preparations containing NaCl
|
GB9613858D0
(en)
*
|
1996-07-02 |
1996-09-04 |
Cortecs Ltd |
Hydrophobic preparations
|
US5905140A
(en)
*
|
1996-07-11 |
1999-05-18 |
Novo Nordisk A/S, Novo Alle |
Selective acylation method
|
DE69731105T2
(de)
*
|
1996-07-11 |
2005-11-17 |
Novo Nordisk A/S |
Verfahren zur selektiven acetylierung
|
US5874111A
(en)
*
|
1997-01-07 |
1999-02-23 |
Maitra; Amarnath |
Process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
|
US5830918A
(en)
|
1997-01-15 |
1998-11-03 |
Terrapin Technologies, Inc. |
Nonpeptide insulin receptor agonists
|
US5898028A
(en)
*
|
1997-03-20 |
1999-04-27 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
US6043214A
(en)
*
|
1997-03-20 |
2000-03-28 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
PE79099A1
(es)
*
|
1997-06-13 |
1999-08-24 |
Lilly Co Eli |
Formulaciones de insulina estables
|
CA2306877A1
(en)
*
|
1997-10-24 |
1999-05-06 |
Eli Lilly And Company |
Insoluble insulin compositions
|
ZA989744B
(en)
*
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
US6211144B1
(en)
*
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
JP3406244B2
(ja)
*
|
1999-04-30 |
2003-05-12 |
伊藤ハム株式会社 |
新規な融合蛋白質からの組み換えインスリンの製造方法
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
PT1430082E
(pt)
*
|
2001-09-07 |
2010-01-15 |
Biocon Ltd |
Métodos de síntese de conjugados de polipéptido de insulina-oligómero, e conjugados de polipéptido de pró-insulina-oligómero e método de síntese dos mesmos
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|